The INFO Project

Johns Hopkins Bloomberg School of Public Health
Español Français Português Population Reports Home Related Resources Contact Us FAQs Site Map Feedback About Population Reports Online Reports Upcoming Reports Press Releases Order
Population Reports Search Population Reports: 
[Or Search POPLINE & other INFOforhealth.org resources]

 

 

 

 L Series
Series L, Number 15 Issues in World Health

Family Planning Choices for Women With HIV

How providers can help women with HIV make reproductive decisions

CONTENTS

Home (Key Points)

Supporting the Reproductive Decisions of Women With HIV

Box: Family Planning Is a Key Strategy to Reduce Mother-to-Child Transmission of HIV

Box: When a Woman With HIV Decides About Pregnancy

Box: Helping Women Talk With Their Partners About Contraception and Safer Sex

Box: Information Communication Technology: Mobile Phones Keep Women With HIV in Contact With Care

Women With HIV Can Safely Use Most Contraceptive Methods

Box: Dual Protection Strategies Help Prevent Pregnancy and STIs

Women With HIV Need the Facts About Pregnancy

Box: What People With HIV Need to Know About Pregnancy and
Preventing Pregnancy

Bibliography

Credits

From INFO's Toolbox
• INFO Report: “Women and HIV: Questions Answered”
• Web Tool: Assess Your Attitudes and Beliefs About People With HIV
• Box: What People With HIV Need to Know About Preventing Pregnancy

Quick Look
• Table 1: Comparing Contraceptive Methods for People with HIV
• Table 2: Drug Interactions: Combined Oral Contraceptives and Antiretroviral (ARV) Medications
• Web Box: Condoms at a Glance

OrderOrder this report
DownloadDownload PDF
E-mailE-mail this page
See More Population ReportsSee Companion INFO Report: “Women and HIV: Questions Answered”
See More Population ReportsSee more Population Reports

Bibliography

  1. ACADEMY FOR EDUCATIONAL DEVELOPMENT (AED). Women's nutrition throughout the life cycle and in the context of HIV and AIDS: Training of trainers module. Washington, DC, AED, May 2005. 107 p.
  2. ALLEN, L.H. Multiple micronutrients in pregnancy and lactation: An overview. American Journal of Clinical Nutrition 81(5): 1206S–1212S. May 2005.
  3. ALLEN, S., MEINZEN-DERR, J., KAUTZMAN, M., ZULU, I., TRASK, S., FIDELI, U., MUSONDA, R., KASOLO, F., GAO, F., and HAWORTH, A. Sexual behavior of HIV discordant couples after HIV counseling and testing. AIDS 17(5): 733–740. Mar. 28, 2003.
  4. AVERT. The different stages of HIV infection. <http://www.avert.org/hivstages.htm> Jun. 26, 2007
  5. AYISI, J.G., VAN EIJK, A.M., NEWMAN, R.D., TER KUILE, F.O., SHI, Y.P., YANG, C., KOLCZAK, M.S., OTIENO, J.A., MISORE, A.O., KAGER, P.A., LAL, R.B., STEKETEE, R.W., and NAHLEN, B.L. Maternal malaria and perinatal HIV transmission, western Kenya. Emerging Infectious Diseases 10(4): 643–652. Apr. 2004.
  6. BAETEN, J.M., LAVREYS, L., SAGAR, M., KREISS, J.K., RICHARDSON, B.A., CHOHAN, B., PANTELEEFF, D., MANDALIYA, K., NDINYA-ACHOLA, J.O., OVERBAUGH, J., FARLEY, T., MWACHARI, C., COHEN, C., CHIPATO, T., JAISAMRARN, U., KIRIWAT, O., and DUERR, A. Effect of contraceptive methods on natural history of HIV: Studies from the Mombasa cohort. Journal of Acquired Immune Deficiency Syndromes 38(Suppl. 1): S18–21. Mar. 2005.
  7. BAETEN, J.M. and OVERBAUGH, J. Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission. Current HIV Research 1(1): 69–86. Jan. 2003.
  8. BAETEN, J.M., RICHARDSON, B.A., LAVREYS, L., RAKWAR, J.P., MANDALIYA, K., BWAYO, J.J., and KREISS, J.K. Female-to-male infectivity of HIV-1 among circumcised and uncircumcised Kenyan men. Journal of Infectious Diseases 191(4): 546–553. Feb 15.
  9. BAILEY, R.C., MOSES, S., PARKER, C.B., AGOT, K., MACLEAN, I., KRIEGER, J.N., WILLIAMS, C.F., CAMPBELL, R.T., and NDINYA-ACHOLA, J.O. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369(9562): 643–656. Feb 24.
  10. BARREIRO, P., DEL ROMERO, J., LEAL, M., HERNANDO, V., ASENCIO, R., DE MENDOZA, C., LABARGA, P., NUNEZ, M., RAMOS, J.T., GONZALEZ-LAHOZ, J., and SORIANO, V. Natural pregnancies in HIV-serodiscordant couples receiving successful antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 43(3): 324–326. Nov. 1, 2006.
  11. BARREIRO, P., DUERR, A., BECKERMAN, K., and SORIANO, V. Reproductive options for HIV-serodiscordant couples. AIDS Review 8(3): 158–170. Jul.–Sep. 2006.
  12. BARROSO, P.F., SCHECHTER, M., CERBINO-NETO, J., ALMEIDA, M.H., LITTLETON, M., and HARRISON, L.H. Sexual activity after initiation of antiretroviral therapy in Brazil. Proceedings of the XIV International AIDS Conference, Barcelona, Spain, Jul. 7–12, 2002.
  13. BAUTISTA, F.S., DE GUZMAN, E.M., and SESCON, J.N. The FamPlan Hotline: Making family planning information just a text away to Filipinos nationwide. Washington, DC, Academy for Educational Development, Sep. 2006. 8 p.
  14. BAYLIES, C. The impact of HIV on family size preference in Zambia. Reproductive Health Matters 8(15): 77–86. May 2000.
  15. BOERMA, J.T. and URASSA, M. Association between female infertility, HIV, and sexual behaviour in rural Tanzania. Boerma, J.T. and Mgalla, Z., eds. In: Women and Infertility in Sub-Saharan Africa. Amsterdam, Royal Tropical Institute, 2001. p. 175–188.
  16. BRAHMBHATT, H., KIGOZI, G., WABWIRE-MANGEN, F., SERWADDA, D., SEWANKAMBO, N., LUTALO, T., WAWER, M.J., ABRAMOWSKY, C., SULLIVAN, D., and GRAY, R. The effects of placental malaria on mother-to-child HIV transmission in Rakai, Uganda. AIDS 17(17): 2539–2541. Nov. 21, 2003.
  17. BRITISH BROADCASTING CORPORATION (BBC). Text messages prove a life-saver. (Cape Town), Jan. 29, 2003.
  18. BROCKLEHURST, P. and FRENCH, R. The association between maternal HIV infection and perinatal outcome: A systematic review of the literature and meta-analysis. British Journal of Obstetrics and Gynaecology 105(8): 836–848. Aug. 1998.
  19. BUJAN, L., DAUDIN, M., MATSUDA, T., RIGHI, L., THAUVIN, L., BERGES, L., IZOPET, J., BERREBI, A., MASSIP, P., and PASQUIER, C. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 18(5): 757–766. Mar. 26, 2004.
  20. CAMPBELL, M., SAHIN-HODOGLUGIL, N.N., and POTTS, M. Barriers to fertility regulation: A review of the literature. Studies in Family Planning 37(2): 87–98. Jun. 2006.
  21. CATES, W., JR. Use of contraception by HIV-infected women. IPPF Medical Bulletin 35(1): 1–2. Feb. 2001.
  22. CATES, W., JR. and RAYMOND, E.G. Emergency contraception—Parsimony and prevention in the medicine cabinet. American Journal of Public Health 87(6): 909–910. Jun. 1997.
  23. CEJTIN, H.E., JACOBSON, L., SPRINGER, G., WATTS, D.H., LEVINE, A., GREENBLATT, R., ANASTOS, K., MINKOFF, H.L., MASSAD, L.S., and SCHMIDT, J.B. Effect of hormonal contraceptive use on plasma HIV-1-RNA levels among HIV-infected women. AIDS 17(11): 1702–1704. Jul. 25, 2003.
  24. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) DEPARTMENT OF HEALTH AND HUMAN SERVICES. Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. Mortality and Morbidity Weekly Report 54(RR–9). Sep. 30, 2005.
  25. CENTRAL STATISTICAL OFFICE (CSO) [ZIMBABWE] and MACRO INTERNATIONAL INC. Zimbabwe Demographic and Health Survey, 2005–06. Calverton, Maryland, CSO and Macro International Inc., 2007.
  26. CHAN, D.J. Factors affecting sexual transmission of HIV-1: Current evidence and implications for prevention. Current HIV Research 3(3): 223–241. Jul. 2005.
  27. CHEN, J.L., PHILIPS, K.A., KANOUSE, D.E., COLLINS, R.L., and MIU, A. Fertility desires and intentions of HIV-positive men and women. Family Planning Perspectives 33(4): 144–152, 165. Jul.-Aug. 2001.
  28. CHEN, K.T., SEGU, M., LUMEY, L.H., KUHN, L., CARTER, R.J., BULTERYS, M., and ABRAMS, E.J. Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus. Obstetrics and Gynecology 106(6): 1341–1348. Dec. 2005.
  29. CHRYSTIE, I.L., MULLEN, J.E., BRAUDE, P.R., ROWELL, P., WILLIAMS, E., ELKINGTON, N., DE RUITER, A., RICE, K., and KENNEDY, J. Assisted conception in HIV discordant couples: Evaluation of semen processing techniques in reducing HIV viral load. Journal of Reproductive Immunology 41(1–2): 301–306. Dec. 1998.
  30. CHU, J.H., GANGE, S.J., ANASTOS, K., MINKOFF, H., CEJTIN, H., BACON, M., LEVINE, A., and GREENBLATT, R.M. Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy. American Journal of Epidemiology 161(9): 881–890. May 1, 2005.
  31. CLEMETSON, D.B., MOSS, G.B., WILLERFORD, D.M., HENSEL, M., EMONYI, W., HOLMES, K.K., PLUMMER, F., NDINYA-ACHOLA, J., ROBERTS, P.L., HILLIER, S., and ET AL. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. Journal of the American Medical Association 269(22): 2860–2864. Jun. 9, 1993.
  32. COHEN, S. Prevention challenges: Reflections on the roles of "fatigue" and "disinhibition". Guttmacher Report on Public Policy 8(2): 11–13. Washington DC.
  33. COHN, S.E., PARK, J.G., WATTS, D.H., STEK, A., HITTI, J., CLAX, P.A., YU, S., and LERTORA, J.J. Depo-medroxyprogesterone in women on antiretroviral therapy: Effective contraception and lack of clinically significant interactions. Clinical Pharmacology and Therapeutics 81(2): 222–227. Feb. 2007.
  34. COLEY, J.L., MSAMANGA, G.I., FAWZI, M.C., KAAYA, S., HERTZMARK, E., KAPIGA, S., SPIEGELMAN, D., HUNTER, D., and FAWZI, W.W. The association between maternal HIV-1 infection and pregnancy outcomes in Dar es Salaam, Tanzania. British Journal of Obstetrics and Gynaecology 108(11): 1125–1133. Nov. 2001.
  35. COOPER, D.A., MYER, L., ZWEIGENTHAL, V., MOODLEY, J., ORNER, P., HARRIES, J., BEKKER, L.G., and BRACKEN, H. Linking various programs: Users' perspectives: HIV+ women & men in Cape Town, South Africa Proceedings of the International Conference on Actions to Strengthen Linkages between Sexual and Reproductive Health and HIV/AIDS, Mumbai, Feb. 4–7, 2007.
  36. COOVADIA, H.M., ROLLINS, N.C., BLAND, R.M., LITTLE, K., COUTSOUDIS, A., BENNISH, M.L., and NEWELL, M.L. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first six months of life: An intervention cohort study. Lancet 369(9567): 1107–1116. Mar. 31, 2007.
  37. COTTINGHAM, J. and HUNTER, D. Chlamydia trachomatis and oral contraceptive use: A quantitative review. Genitourinary Medicine 68(4): 209–216. Aug.
  38. COUTSOUDIS, A., PILLAY, K., KUHN, L., SPOONER, E., TSAI, W.Y., and COOVADIA, H.M. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: Prospective cohort study from Durban, South Africa. AIDS 15(3): 379–387. Feb. 16, 2001.
  39. CRITELLI, J.W. and SUIRE, D.M. Obstacles to condom use: The combination of other forms of birth control and short-term monogamy. Journal of American College Health 46(5): 215–219. Mar. 1998.
  40. DE BRUYN, M. Reproductive choice and women living with HIV/AIDS. Chapel Hill, North Carolina, Ipas, Dec. 2002. 33 p.
  41. DE BRUYN, M. Reproductive rights for women affected by HIV/AIDS? A project to monitor Millennium Development Goals 5 and 6. Chapel Hill, North Carolina, Ipas, Aug. 2005. 99 p.
  42. DE BRUYN, M., NJOKO, M., ODHIAMBO, D., and PAXTON, S. HIV/AIDS, pregnancy and abortion-related care: A preliminary inquiry. Chapel Hill, North Carolina, Ipas, Dec. 2002.
  43. DE COCK, K.M., FOWLER, M.G., MERCIER, E., DE VINCENZI, I., SABA, J., HOFF, E., ALNWICK, D.J., ROGERS, M., and SHAFFER, N. Prevention of mother-to-child HIV transmission in resource-poor countries: Translating research into policy and practice. Journal of the American Medical Association 283(9): 1175–1182. Mar. 1, 2000.
  44. DE VINCENZI, I., JADAND, C., COUTURIER, E., BRUNET, J.B., GALLAIS, H., GASTAUT, J.A., GOUJARD, C., DEVEAU, C., and MEYER, L. Pregnancy and contraception in a French cohort of HIV-infected women. SEROCO Study Group. AIDS 11(3): 333–338. Mar. 1997.
  45. DELVAUX, T. and NOSTLINGER, C. Reproductive choice for women and men living with HIV: Contraception, abortion and fertility. Reproductive Health Matters 15(29 Suppl): 46–66. May 2007.
  46. DENISON, R. The toughest decision I ever made: How my husband and I approached pregnancy, knowing that I have HIV. The Body: The Complete HIV/AIDS Resource, Oct. 1998.
  47. DESCHAMPS, M.D., GRAND PIERRE, D.P., and THEODORE, T.H. Reproductive health interventions in voluntary counseling testing (VCT) centers for HIV/AIDS prevention and care. Proceedings of the XV International AIDS Conference, Bangkok, Jul. 11–16, 2004
  48. DESCHAMPS, M.M., PAPE, J.W., DESVARIEUX, M., WILLIAMS-RUSSO, P., MADHAVAN, S., HO, J.L., and JOHNSON, W.D., JR. A prospective study of HIV-seropositive asymptomatic women of childbearing age in a developing country. Journal of Acquired Immune Deficiency Syndromes 6(5): 446–451. May 1993.
  49. DESGREES DU LOU, A., MSELLATI, P., VIHO, I., YAO, A., YAPI, D., KASSI, P., WELFFENS-EKRA, C., MANDELBROT, L., and DABIS, F. Contraceptive use, protected sexual intercourse and incidence of pregnancies among African HIV-infected women. DITRAME ANRS 049 Project, Abidjan 1995–2000. International Journal of STD and AIDS 13(7): 462–446. Jul. 2002.
  50. DESGREES DU LOU, A., MSELLATI, P., YAO, A., NOBA, V., VIHO, I., RAMON, R., WELFFENS-EKRA, C., and DABIS, F. Impaired fertility in HIV-1-infected pregnant women: A clinic-based survey in Abidjan, Côte d'Ivoire, 1997. AIDS 13(4): 517–521. Mar. 11, 1999.
  51. DEVOTO, L., FUENTES, A., PALOMINO, A., ESPINOZA, A., KOHEN, P., RANTA, S., and VON HERTZEN, H. Pharmacokinetics and endometrial tissue levels of levonorgestrel after administration of a single 1.5-mg dose by the oral and vaginal route. Fertility and Sterility 84(1): 46–51. Jul. 2005.
  52. DRAKE, A.L., JOHN-STEWART, G.C., WALD, A., MBORI-NGACHA, D.A., BOSIRE, R., WAMALWA, D.C., LOHMAN-PAYNE, B.L., ASHLEY-MORROW, R., COREY, L., and FARQUHAR, C. Herpes simplex virus type 2 and risk of intrapartum human immunodeficiency virus transmission. Obstetrics and Gynecology 109(2 Pt 1): 403–409. Feb. 2007.
  53. DULIOUST, E., DU, A.L., COSTAGLIOLA, D., GUIBERT, J., KUNSTMANN, J.M., HEARD, I., JUILLARD, J.C., SALMON, D., LERUEZ-VILLE, M., MANDELBROT, L., ROUZIOUX, C., SICARD, D., ZORN, J.R., JOUANNET, P., and DE ALMEIDA, M. Semen alterations in HIV-1 infected men. Human Reproduction 17(8): 2112–2118. Aug. 2002.
  54. DUNN, D.T., NEWELL, M.L., ADES, A.E., and PECKHAM, C.S. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340(8819): 585–588. Sep. 5, 1992.
  55. ELLIOTT, J. AIDS ravages Rwanda. BBC News wire service Apr. 19, 2003.
  56. ESHLEMAN, S.H., HOOVER, D.R., CHEN, S., HUDELSON, S.E., GUAY, L.A., MWATHA, A., FISCUS, S.A., MMIRO, F., MUSOKE, P., JACKSON, J.B., KUMWENDA, N., and TAHA, T. Nevirapine (NVP) resistance in women with HIV-1 subtype C, compared with subtypes A and D, after the administration of single-dose NVP. Journal of Infectious Disease 192(1): 30–36. Jul. 1, 2005.
  57. EUROPEAN COLLABORATIVE STUDY. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. Clinical Infectious Diseases 40(3): 458–465. Feb. 1, 2005.
  58. EUROPEAN MODE OF DELIVERY COLLABORATION. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: A randomised clinical trial. Lancet 353(9158): 1035–1039. Mar. 27, 1999.
  59. EUROPEAN STUDY GROUP ON HETEROSEXUAL TRANSMISSION OF HIV. Comparison of female to male and male to female transmission of HIV in 563 stable couples. British Medical Journal 304(6830): 809–813. Mar. 28, 1992.
  60. FAISEL, H. and PITTROF, R. Vitamin A and causes of maternal mortality: Association and biological plausibility. Public Health Nutrition 3(3): 321–327. Sep. 2000.
  61. FAMILY HEALTH INTERNATIONAL (FHI). Integrating services. Network 3(23). FHI. 2004.
  62. FANTA PROJECT. Nutritional care and support of pregnant and lactating women or adolescent girls with HIV/AIDS. Nov. 6, 2003. (PowerPoint Presentation)
  63. FARLEY, T.M., ROSENBERG, M.J., ROWE, P.J., CHEN, J.H., and MEIRIK, O. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 339(8796): 785–788. Mar. 28, 1992.
  64. FAWZI, W., MSAMANGA, G., RENJIFO, B., SPIEGELMAN, D., URASSA, E., HASHEMI, L., ANTELMAN, G., ESSEX, M., and HUNTER, D. Predictors of intrauterine and intrapartum transmission of HIV-1 among Tanzanian women. AIDS 15(9): 1157–1165. Jun. 15, 2001.
  65. FIORE, S., NEWELL, M.L., and THORNE, C. Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS 18(6): 933–938. Apr. 9, 2004.
  66. FLYS, T., NISSLEY, D.V., CLAASEN, C.W., JONES, D., SHI, C., GUAY, L.A., MUSOKE, P., MMIRO, F., STRATHERN, J.N., JACKSON, J.B., ESHLEMAN, J.R., and ESHLEMAN, S.H. Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012. Journal of Infectious Disease 192(1): 24–29. Jul. 1, 2005.
  67. FLYS, T.S., DONNELL, D., MWATHA, A., NAKABIITO, C., MUSOKE, P., MMIRO, F., JACKSON, J.B., GUAY, L.A., and ESHLEMAN, S.H. Persistence of K103N-containing HIV-1 variants after single-dose nevirapine for prevention of HIV-1 mother-to-child transmission. Journal of Infectious Disease 195(5): 711-715. Mar. 1, 2007.
  68. FORSYTH, B.W., DAVIS, J.A., FREUDIGMAN, K.A., KATZ, K.H., and ZELTERMAN, D. Pregnancy and birth rates among HIV-infected women in the United States: The confounding effects of illicit drug use. AIDS 16(3): 471–479. Feb. 15, 2002.
  69. FRENCH, R. and BROCKLEHURST, P. The effect of pregnancy on survival in women infected with HIV: A systematic review of the literature and meta-analysis. British Journal of Obstetrics and Gynaecology 105(8): 827–835. Aug. 1998.
  70. FUNDARO, C., GENOVESE, O., RENDELI, C., TAMBURRINI, E., and SALVAGGIO, E. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS 16(2): 299–300. Jan. 25, 2002.
  71. GALLAGHER, M., MALHOTRA, I., MUNGAI, P.L., WAMACHI, A.N., KIOKO, J.M., OUMA, J.H., MUCHIRI, E., and KING, C.L. The effects of maternal helminth and malaria infections on mother-to-child HIV transmission. AIDS 19(16): 1849–1855. Nov. 4, 2005.
  72. GARCIA, P.M., KALISH, L.A., PITT, J., MINKOFF, H., QUINN, T.C., BURCHETT, S.K., KORNEGAY, J., JACKSON, B., MOYE, J., HANSON, C., ZORRILLA, C., and LEW, J.F. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. New England Journal of Medicine 341(6): 394–402. Aug. 5, 1999.
  73. GHANEM, K.G., SHAH, N., KLEIN, R.S., MAYER, K.H., SOBEL, J.D., WARREN, D.L., JAMIESON, D.J., DUERR, A.C., and ROMPALO, A.M. Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. Journal of Infectious Diseases 191(3): 358–366. Feb. 1, 2005.
  74. GILLING-SMITH, C. HIV prevention. Assisted reproduction in HIV-discordant couples. AIDS Reader 10(10): 581–587. Oct. 2000.
  75. GIULIANO, M., GUIDOTTI, G., ANDREOTTI, M., PIRILLO, M.F., VILLANI, P., LIOTTA, G., MARAZZI, M.C., MANCINI, M.G., CUSATO, M., GERMANO, P., LOUREIRO, S., CEFFA, S., REGAZZI, M., VELLA, S., and PALOMBI, L. Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: A study within the drug resource enhancement against AIDS and malnutrition program. Journal of Acquired Immune Deficiency Syndromes 44(3): 286–291. Mar. 1, 2007.
  76. GLYNN, J.R., BUVE, A., CARAEL, M., KAHINDO, M., MACAULEY, I.B., MUSONDA, R.M., JUNGMANN, E., TEMBO, F., and ZEKENG, L. Decreased fertility among HIV-1-infected women attending antenatal clinics in three African cities. Journal of Acquired Immune Deficiency Syndromes 25(4): 345–352. Dec. 1, 2000.
  77. GOTTLIEB, G.S., NICKLE, D.C., JENSEN, M.A., WONG, K.G., GROBLER, J., LI, F., LIU, S.L., RADEMEYER, C., LEARN, G.H., KARIM, S.S., WILLIAMSON, C., COREY, L., MARGOLICK, J.B., and MULLINS, J.I. Dual HIV-1 infection associated with rapid disease progression. Lancet 363(9409): 619–622. Feb. 21, 2004.
  78. GRAY, R.H., KIGOZI, G., SERWADDA, D., MAKUMBI, F., WATYA, S., NALUGODA, F., KIWANUKA, N., MOULTON, L.H., CHAUDHARY, M.A., CHEN, M.Z., SEWANKAMBO, N.K., WABWIRE-MANGEN, F., BACON, M.C., WILLIAMS, C.F., OPENDI, P., REYNOLDS, S.J., LAEYENDECKER, O., QUINN, T.C., and WAWER, M.J. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369(9562): 657–666. Feb. 24, 2007.
  79. GRAY, R.H., KIWANUKA, N., QUINN, T.C., SEWANKAMBO, N.K., SERWADDA, D., MANGEN, F.W., LUTALO, T., NALUGODA, F., KELLY, R., MEEHAN, M., CHEN, M.Z., LI, C., and WAWER, M.J. Male circumcision and HIV acquisition and transmission: Cohort studies in Rakai, Uganda. Rakai Project Team. AIDS 14(15): 2371–2381. Oct. 20, 2000.
  80. GRAY, R.H., LI, X., KIGOZI, G., SERWADDA, D., BRAHMBHATT, H., WABWIRE-MANGEN, F., NALUGODA, F., KIDDUGAVU, M., SEWANKAMBO, N., QUINN, T.C., REYNOLDS, S.J., and WAWER, M.J. Increased risk of incident HIV during pregnancy in Rakai, Uganda: A prospective study. Lancet 366(9492): 1182–1188. Oct. 1, 2005.
  81. GRAY, R.H., WAWER, M.J., BROOKMEYER, R., SEWANKAMBO, N.K., SERWADDA, D., WABWIRE-MANGEN, F., LUTALO, T., LI, X., VANCOTT, T., and QUINN, T.C. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357(9263): 1149–1153. Apr. 14, 2001.
  82. GRAY, R.H., WAWER, M.J., SERWADDA, D., SEWANKAMBO, N., LI, C., WABWIRE-MANGEN, F., PAXTON, L., KIWANUKA, N., KIGOZI, G., KONDE-LULE, J., QUINN, T.C., GAYDOS, C.A., and MCNAIRN, D. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 351(9096): 98–103. Jan. 10, 1998.
  83. GUEST, F. HIV/AIDS and reproductive health. In: Contraceptive Technology. New York, Ardent Media, 2004. p. 153–189.
  84. GUTTMACHER INSTITUTE. Meeting the sexual and reproductive health needs of people living with HIV. Guttmacher Institute, Nov. 2006. (In Brief, 2006 Series, No 6) 4 p.
  85. HALL, M. My pill: The contraceptive pill txt alert service. 2007.
  86. HAMERS, F.F. and DOWNS, A.M. HIV in Central and Eastern Europe. Lancet 361(9362): 1035–1044. Mar. 22, 2003.
  87. HANKINS, C., TRAN, T., and LAPOINTE, N. Sexual behavior and pregnancy outcome in HIV-infected women. Canadian Women's HIV Study Group. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 18(5): 479–487. Aug. 15, 1998.
  88. HATZELL, T. and E.B., R. Final report: Assessment of how family planning and HIV services can be integrated in Zimbabwe. Durham, North Carolina, Family Health International, Feb. 2006. (Unpublished)
  89. HEIKINHEIMO, O., LEHTOVIRTA, P., SUNI, J., and PAAVONEN, J. The levonorgestrel-releasing intrauterine system (LNG-IUS) in HIV-infected women—Effects on bleeding patterns, ovarian function and genital shedding of HIV. Human Reproduction 21(11): 2857–2861. Nov. 2006.
  90. HIV INSITE. Database of antiretroviral drug interactions: Interactions between hormonal agents and antiretrovirals. University of California San Francisco Center for HIV Information, 2007.
  91. HOFFMANN, C., ROCKSTROH, J.K., and KAMPS, B.S., eds. HIV Medicine 2006. Paris, Flying Publisher, 2006. 825 p.
  92. HUNTER, S.C., ISINGO, R., BOERMA, J.T., URASSA, M., MWALUKO, G.M., and ZABA, B. The association between HIV and fertility in a cohort study in rural Tanzania. Journal of Biosocial Science 35(2): 189–199. Apr. 2003.
  93. HUSLER, J. Evaluation of the On Cue compliance service pilot. Capetown, Mar. 29, 2005. 42 p.
  94. ILIFF, P.J., PIWOZ, E.G., TAVENGWA, N.V., ZUNGUZA, C.D., MARINDA, E.T., NATHOO, K.J., MOULTON, L.H., WARD, B.J., and HUMPHREY, J.H. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS 19(7): 699–708. Apr. 29, 2005.
  95. INTERNATIONAL PERINATAL HIV GROUP. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective cohort studies. New England Journal of Medicine 340(13): 977–987. Apr. 1, 1999.
  96. INTERNATIONAL PLANNED PARENTHOOD FEDERATION (IPPF). Dreams & desires: Sexual and reproductive health experiences of HIV positive women. IPPF, Nov. 2004.
  97. IOANNIDIS, J.P., ABRAMS, E.J., AMMANN, A., BULTERYS, M., GOEDERT, J.J., GRAY, L., KORBER, B.T., MAYAUX, M.J., MOFENSON, L.M., NEWELL, M.L., SHAPIRO, D.E., TEGLAS, J.P., and WILFERT, C.M. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1000 copies/ml. Journal of Infectious Diseases 183(4): 539–545. Feb. 15, 2001.
  98. IVERS, L.C., KENDRICK, D., and DOUCETTE, K. Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature. Clinical Infectious Diseases 41(2): 217–224. Jul. 15, 2005.
  99. JACOBSTEIN, R. and PILE, J. Female sterilization: The most popular method of modern contraception. INFO Project, Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs, Jan. 5, 2005. (Global Health Technical Briefs)
  100. JOHN, G.C., NDUATI, R.W., MBORI-NGACHA, D.A., RICHARDSON, B.A., PANTELEEFF, D., MWATHA, A., OVERBAUGH, J., BWAYO, J., NDINYA-ACHOLA, J.O., and KREISS, J.K. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: Association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. Journal of Infectious Diseases 183(2): 206–212. Jan. 15, 2001.
  101. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS). AIDS epidemic update. Special report on HIV prevention. Geneva, UNAIDS, Dec. 2005. 96 p.
  102. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS). 2006 report on the global AIDS epidemic. Geneva, UNAIDS, May 2006. 629 p.
  103. JOINT UNITED NATIONS PROGRAMME ON HIV/AIDS (UNAIDS) and WORLD HEALTH ORGANIZATION (WHO). New data on male circumcision and HIV prevention: Policy and programme implications WHO/UNAIDS technical consultation. UNAIDS, Mar. 20, 2007.
  104. JURRIAANS, S., VAN GEMEN, B., WEVERLING, G.J., VAN STRIJP, D., NARA, P., COUTINHO, R., KOOT, M., SCHUITEMAKER, H., and GOUDSMIT, J. The natural history of HIV-1 infection: Virus load and virus phenotype independent determinants of clinical course? Virology 204(1): 223–233. Oct. 1994.
  105. KAPIGA, S.H., LYAMUYA, E.F., LWIHULA, G.K., and HUNTER, D.J. The incidence of HIV infection among women using family planning methods in Dar es Salaam, Tanzania. AIDS 12(1): 75–84. Jan. 1, 1998.
  106. KAPIGA, S.H., SAM, N.E., BANG, H., NI, Q., AO, T.T., KIWELU, I., CHIDUO, S., NDIBE, U., SEAGE, G., 3RD, COPLAN, P., SHAO, J., ROSENBERG, Z.F., and ESSEX, M. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. Journal of Infectious Diseases 195(9): 1260–1269. May 1, 2007.
  107. KAUSHIC, C., ZHOU, F., MURDIN, A.D., and WIRA, C.R. Effects of estradiol and progesterone on susceptibility and early immune responses to chlamydia trachomatis infection in the female reproductive tract. Infection and Immunity 68(7): 4207–4216. Jul. 2000.
  108. KLEINSCHMIDT, I., REES, H., DELANY, S., SMITH, D., DINAT, N., NKALA, B., and MCINTYRE, J.A. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 75(6): 461–467. Jun. 2007.
  109. KOVACS, A., WASSERMAN, S.S., BURNS, D., WRIGHT, D.J., COHN, J., LANDAY, A., WEBER, K., COHEN, M., LEVINE, A., MINKOFF, H., MIOTTI, P., PALEFSKY, J., YOUNG, M., and REICHELDERFER, P. Determinants of HIV-1 shedding in the genital tract of women. Lancet 358(9293): 1593–1601. Nov. 10, 2001.
  110. KOWALSKA, A., NIEMIEC, T., EL MIDAOUI, A., and BURKACKA, E. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women. Medycyna Wieku Rozwojowego 7(4 Pt 1): 459–468. Oct.-Dec. 2003.
  111. KREISS, J., NGUGI, E., HOLMES, K., NDINYA-ACHOLA, J., WAIYAKI, P., ROBERTS, P.L., RUMINJO, I., SAJABI, R., KIMATA, J., FLEMING, T.R., and ET AL. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. Journal of the American Medical Association 268(4): 477–482. Jul. 22–29, 1992.
  112. LADNER, J., LEROY, V., SIMONON, A., KARITA, E., BOGAERTS, J., DE CLERCQ, A., VAN DE PERRE, P., and DABIS, F. HIV infection, malaria, and pregnancy: A prospective cohort study in Kigali, Rwanda. American Journal of Tropical Medicine and Hygiene 66(1): 56–60. Jan. 2002.
  113. LAGA, M., SCHWARTLANDER, B., PISANI, E., SOW, P.S., and CARAEL, M. To stem HIV in Africa, prevent transmission to young women. AIDS 15(7): 931–934. May 4, 2001.
  114. LAPAIRE, O., IRION, O., KOCH-HOLCH, A., HOLZGREVE, W., RUDIN, C., and HOESLI, I. Increased peri- and post-elective cesarean section morbidity in women infected with human immunodeficiency virus-1: A case-controlled multicenter study. Archives of Gynecology and Obstetrics 274(3): 165–169. Jun. 2006.
  115. LAVREYS, L., BAETEN, J.M., CHOHAN, V., MCCLELLAND, R.S., HASSAN, W.M., RICHARDSON, B.A., MANDALIYA, K., NDINYA-ACHOLA, J.O., and OVERBAUGH, J. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clinical Infectious Diseases 42(9): 1333–1339. May 1, 2006.
  116. LAVREYS, L., BAETEN, J.M., MARTIN, H.L., JR., OVERBAUGH, J., MANDALIYA, K., NDINYA-ACHOLA, J., and KREISS, J.K. Hormonal contraception and risk of HIV-1 acquisition: Results of a 10-year prospective study. AIDS 18(4): 695–697. Mar. 5, 2004.
  117. LAVREYS, L., CHOHAN, V., OVERBAUGH, J., HASSAN, W., and MCCLELLAND, R.S. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 18: 2179–2184. 2004.
  118. LEHTOVIRTA, P., PAAVONEN, J., and HEIKINHEIMO, O. Experience with the levonorgestrel-releasing intrauterine system among HIV-infected women. Contraception 75(1): 37–39. Jan. 2007.
  119. LORENZI, P., SPICHER, V.M., LAUBEREAU, B., HIRSCHEL, B., KIND, C., RUDIN, C., IRION, O., and KAISER, L. Antiretroviral therapies in pregnancy: Maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study. AIDS 12(18): F241–247. Dec. 24, 1998.
  120. LYERLY, A.D. and ANDERSON, J. Human immunodeficiency virus and assisted reproduction: Reconsidering evidence, reframing ethics. Fertility and Sterility 75(5): 843–858. May 2001.
  121. MACNEIL, N. and GILCHRIST, A. Beyond pregnancy: Women specific HIV health issues. Autumn 1995.
  122. MADKAN, V.K., GIANCOLA, A.A., SRA, K.K., and TYRING, S.K. Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases. Archives of Dermatology 142(3): 365–370. Mar. 2006.
  123. MAGALHAES, J., AMARAL, E., GIRALDO, P.C., and SIMOES, J.A. HIV infection in women: Impact on contraception. Contraception 66(2): 87–91. Aug. 2002.
  124. MAHENDRA, V.S., GILBORN, L., GEORGE, B., SAMSON, L., MUDOI, R., JADAV, S., GUPTA, I., BHARAT, S., and DALY, C. Reducing AIDS-related stigma and discrimination in Indian hospitals. Horizons final report. New Delhi, Population Council, Apr. 2006. 64 p.
  125. MAIQUES-MONTESINOS, V., CERVERA-SANCHEZ, J., BELLVER-PRADAS, J., ABAD-CARRASCOSA, A., and SERRA-SERRA, V. Post-cesarean section morbidity in HIV-positive women. Acta Obstetricia et Gynecologica Scandinavica 78(9): 789–792. Oct. 1999.
  126. MARCOLLET, A., GOFFINET, F., FIRTION, G., PANNIER, E., LE BRET, T., BRIVAL, M.L., and MANDELBROT, L. Differences in postpartum morbidity in women who are infected with the human immunodeficiency virus after elective cesarean delivery, emergency cesarean delivery, or vaginal delivery. American Journal of Obstetrics and Gynecology 186(4): 784–789. Apr. 2002.
  127. MARIE STOPES INTERNATIONAL. Sextext SMS serivce: For sexual health advice. 2007.
  128. MARTIN, H.L., JR., NYANGE, P.M., RICHARDSON, B.A., LAVREYS, L., MANDALIYA, K., JACKSON, D.J., NDINYA-ACHOLA, J.O., and KREISS, J. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. Journal of Infectious Diseases 178(4): 1053–1059. Oct. 1998.
  129. MARTIN, H.L., RICHARDSON, B.A., NYANGE, P.M., LAVREYS, L., HILLIER, S.L., CHOHAN, B., MANDALIYA, K., NDINYA-ACHOLA, J.O., BWAYO, J., and KREISS, J. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. Journal of Infectious Diseases 180(6): 1863–1868. Dec. 1999.
  130. MASTRO, T.D. and DE VINCENZI, I. Probabilities of sexual HIV-1 transmission. AIDS 10(Suppl. A): S75–82. 1996.
  131. MAYER, K., POBLETE, R., HATHAWAY, B., PALIC, B., PILSON, R., SIEMON-HRYCZYK, P., and DE CAPRARIIS, P. Efficacy, effect of oral contraceptives, and adherence in HIV infected women receiving Fortovase (saquinavir) soft gel capsule (SQV-SGC; FTV) thrice (TID) and twice (BID) daily regimens. XIII International AIDS Conference, Durban, Jul. 9–14, 2000
  132. MCCLELLAND, R.S., WANG, C.C., MANDALIYA, K., OVERBAUGH, J., REINER, M.T., PANTELEEFF, D.D., LAVREYS, L., NDINYA-ACHOLA, J., BWAYO, J.J., and KREISS, J.K. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 15(1): 105–110. Jan 5.
  133. MCINTYRE, J. Mothers infected with HIV. British Medical Bulletin, Vol. 67, No. 1, Dec. 2003. p. 127–135.
  134. MELLORS, J.W., KINGSLEY, L.A., RINALDO, C.R., JR., TODD, J.A., HOO, B.S., KOKKA, R.P., and GUPTA, P. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Annals of Internal Medicine 122(8): 573–579. Apr. 15, 1995.
  135. MILDVAN, D., YARRISH, R., MARSHAK, A., HUTMAN, H.W., and MCDONOUGH, M. Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women. Journal of Acquired Immune Deficiency Syndromes 29(5): 471–477. Apr. 15, 2002.
  136. MINKOFF, H., HERSHOW, R., WATTS, D.H., FREDERICK, M., CHENG, I., TUOMALA, R., PITT, J., ZORRILLA, C.D., HAMMILL, H., ADENIYI-JONES, S.K., and THOMPSON, B. The relationship of pregnancy to human immunodeficiency virus disease progression. American Journal of Obstetrics and Gynecology 189(2): 552–559. Aug. 2003.
  137. MINNIS, A.M. and PADIAN, N.S. Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: Current evidence and future research directions. Sexually Transmitted Infections 81(3): 193–200. Jun. 2005.
  138. MITCHELL, H.S. and STEPHENS, E. Contraception choice for HIV positive women. Sexually Transmitted Infections 80(3): 167–173. Jun. 2004.
  139. MOODLEY, J. and MOODLEY, D. Management of human immunodeficiency virus infection in pregnancy. Best Practice and Research Clinical Obstetrics and Gynaecology 19(2): 169–183. Apr. 2005.
  140. MOR, E., SAADAT, P., KIVES, S., WHITE, E., REID, R.L., PAULSON, R.J., and STANCZYK, F.Z. Comparison of vaginal and oral administration of emergency contraception. Fertility and Sterility 84(1): 40–45. Jul. 2005.
  141. MORRISON, C. Contraception and the risk of HIV acquisition: Current knowledge and research needs. Proceedings of the Review of Priorities in Research on Hormonal Contraception and IUDs and HIV Infection Technical Meeting, Geneva, Mar. 13–15, 2007.
  142. MORRISON, C., KWOK, C., CHEN, P.L., DEMERS, K., VAN DER POL, B., CHIPATO, T., ARTS, E., and SALATA, R. Predictors of viral setpoint among African women with primary HIV-1 infection. Proceedings of the XVI International AIDS Conference, Toronto, Jul. 13–18, 2006.
  143. MORRISON, C.S., RICHARDSON, B.A., MMIRO, F., CHIPATO, T., CELENTANO, D.D., LUOTO, J., MUGERWA, R., PADIAN, N., RUGPAO, S., BROWN, J.M., CORNELISSE, P., and SALATA, R.A. Hormonal contraception and the risk of HIV acquisition. AIDS 21(1): 85–95. Jan. 2, 2007.
  144. MORRISON, C.S., SEKADDE-KIGONDU, C., SINEI, S.K., WEINER, D.H., and KWOK, C. Is the intrauterine device appropriate contraception for HIV-1-infected women? British Journal of Obstetrics and Gynaecology 108(8): 784–790. Aug. 2001.
  145. MORRISON, C.S., WANG, J., VAN DER POL, B., PADIAN, N., SALATA, R.A., and RICHARDSON, B.A. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe. AIDS 21(8): 1027–1034. May 11, 2007.
  146. MOSTAD, S.B., OVERBAUGH, J., DEVANGE, D.M., WELCH, M.J., CHOHAN, B., MANDALIYA, K., NYANGE, P., MARTIN, H.L., JR., NDINYA-ACHOLA, J., BWAYO, J.J., and KREISS, J.K. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 350(9082): 922–927. Sep. 27, 1997.
  147. MOUNT, A.M., MWAPASA, V., ELLIOTT, S.R., BEESON, J.G., TADESSE, E., LEMA, V.M., MOLYNEUX, M.E., MESHNICK, S.R., and ROGERSON, S.J. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet 363(9424): 1860–1867. Jun. 5, 2004.
  148. MURPHY, D., LYNCH, M., DESMOND, N., and MULCAHY, F.M. Contraceptive practices in HIV seropositive females in Ireland. International Journal of STD and AIDS 4(2): 107–109. Mar./Apr. 1993.
  149. MWAPASA, V., ROGERSON, S.J., KWIEK, J.J., WILSON, P.E., MILNER, D., MOLYNEUX, M.E., KAMWENDO, D.D., TADESSE, E., CHALULUKA, E., and MESHNICK, S.R. Maternal syphilis infection is associated with increased risk of mother-to-child transmission of HIV in Malawi. AIDS 20(14): 1869–1877. Sep. 11, 2006.
  150. MYER, L., DENNY, L., WRIGHT, T.C., and KUHN, L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. International Journal of Epidemiology. Dec. 14, 2006.
  151. NAGOT, N., OUEDRAOGO, A., FOULONGNE, V., KONATE, I., WEISS, H.A., VERGNE, L., DEFER, M.C., DJAGBARE, D., SANON, A., ANDONABA, J.B., BECQUART, P., SEGONDY, M., VALLO, R., SAWADOGO, A., VAN DE PERRE, P., and MAYAUD, P. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. New England Journal of Medicine 356(8): 790–799. Feb. 22, 2007.
  152. NAKAYIWA, S., ABANG, B., PACKEL, L., LIFSHAY, J., PURCELL, D.W., KING, R., EZATI, E., MERMIN, J., COUTINHO, A., and BUNNELL, R. Desire for children and pregnancy risk behavior among HIV-infected men and women in Uganda. AIDS and Behavior 10(Suppl. 4): S95–104. Jul. 2006.
  153. NANDA, K. Hormonal contraceptive use in women treated with antiretroviral drugs. Meeting of the Expert Working Group, Oct. 21–24, 2003, Geneva, Oct. 2003. (Unpublished)
  154. NDUATI, R., JOHN, G., MBORI-NGACHA, D., RICHARDSON, B., OVERBAUGH, J., MWATHA, A., NDINYA-ACHOLA, J., BWAYO, J., ONYANGO, F.E., HUGHES, J., and KREISS, J. Effect of breastfeeding and formula feeding on transmission of HIV-1: A randomized clinical trial. Journal of the American Medical Association 283(9): 1167–1174. Mar. 1, 2000.
  155. NEBIE, Y., MEDA, N., LEROY, V., MANDELBROT, L., YARO, S., SOMBIE, I., CARTOUX, M., TIENDREBEOGO, S., DAO, B., OUANGRE, A., NACRO, B., FAO, P., KY-ZERBO, O., VAN DE PERRE, P., and DABIS, F. Sexual and reproductive life of women informed of their HIV seropositivity: A prospective cohort study in Burkina Faso. Journal of Acquired Immune Deficiency Syndromes 28(4): 367–372. Dec. 1, 2001.
  156. NGUYEN, R.H., GANGE, S.J., WABWIRE-MANGEN, F., SEWANKAMBO, N.K., SERWADDA, D., WAWER, M.J., QUINN, T.C., and GRAY, R.H. Reduced fertility among HIV-infected women associated with viral load in Rakai district, Uganda. International Journal of STD and AIDS 17(12): 842–846. Dec. 2006.
  157. NICOLOSI, A., CORREA LEITE, M.L., MUSICCO, M., ARICI, C., GAVAZZENI, G., and LAZZARIN, A. The efficiency of male-to-female and female-to-male sexual transmission of the human immunodeficiency virus: A study of 730 stable couples. Italian Study Group on HIV Heterosexual Transmission. Epidemiology 5(6): 570–575. Nov. 1994.
  158. NICOPOULLOS, J.D., ALMEIDA, P.A., RAMSAY, J.W., and GILLING-SMITH, C. The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Human Reproduction 19(10): 2289–2297. Oct. 2004.
  159. NTOZI, J.P.M. Impact of HIV/AIDS on fertility in sub-Saharan Africa. Proceedings of the Fourth Meeting of the Follow-up Committee on the Implementation of the DND and the ICPD-P, Yaounde, Cameroon, Jan. 28–31, 2002.
  160. O'BRIEN, W.A., HARTIGAN, P.M., MARTIN, D., ESINHART, J., HILL, A., BENOIT, S., RUBIN, M., SIMBERKOFF, M.S., and HAMILTON, J.D. Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. New England Journal of Medicine 334(7): 426–431. Feb. 15, 1996.
  161. OGILVIE, G.S., PALEPU, A., REMPLE, V.P., MAAN, E., HEATH, K., MACDONALD, G., CHRISTILAW, J., BERKOWITZ, J., FISHER, W.A., and BURDGE, D.R. Fertility intentions of women of reproductive age living with HIV in British Columbia, Canada. AIDS 21(Suppl. 1): S83–88. Jan. 2007.
  162. OSTERIA, T.S. Strengthening social acceptance of family planning in the Philippines: A communication and advocacy project. Analysis of the family planning hotline: Questions and answers. Manila, De La Salle University, Yuchengco Center, 2004. 55 p.
  163. OUELLET, D., HSU, A., QIAN, J., LOCKE, C.S., EASON, C.J., CAVANAUGH, J.H., LEONARD, J.M., and GRANNEMAN, G.R. Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers. British Journal of Clinical Pharmacology 46(2): 111–116. Aug. 1998.
  164. PADIAN, N.S., SHIBOSKI, S.C., GLASS, S.O., and VITTINGHOFF, E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: Results from a ten-year study. American Journal of Epidemiology 146(4): 350–357. Aug. 15, 1997.
  165. PAIVA, V., FILIPE, E.V., SANTOS, N., LIMA, T.N., and SEGURADO, A. The right to love: The desire for parenthood among men living with HIV. Reproductive Health Matters 11(22): 91–100. Nov. 2003.
  166. PANEL ON ANTIRETROVIRAL GUIDELINES FOR ADULT AND ADOLESCENTS. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services, Oct. 10, 2006. 113 p.
  167. PANTHER, L.A., TUCKER, L., XU, C., TUOMALA, R.E., MULLINS, J.I., and ANDERSON, D.J. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. Journal of Infectious Diseases 181(2): 555–563. Feb. 2000.
  168. PAPATHAKIS, P. and ROLLINS, N. HIV and nutrition: Pregnant and lactating women. Consultation on nutrition and HIV/AIDS in Africa: Evidence, lessons and recommendations for action, Apr. 13–15, 2005, Durban, World Health Organization, 2005. 41 p.
  169. PARISE, M.E., AYISI, J.G., NAHLEN, B.L., SCHULTZ, L.J., ROBERTS, J.M., MISORE, A., MUGA, R., OLOO, A.J., and STEKETEE, R.W. Efficacy of sulfadoxine-pyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. American Journal of Tropical Medicine and Hygiene 59(5): 813–822. Nov. 1998.
  170. PEDRAZA, M.A., DEL ROMERO, J., ROLDAN, F., GARCIA, S., AYERBE, M.C., NORIEGA, A.R., and ALCAMI, J. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. Journal of Acquired Immune Deficiency Syndromes 21(2): 120–125. Jun. 1, 1999.
  171. PILLAY, T., STURM, A.W., KHAN, M., ADHIKARI, M., MOODLEY, J., CONNOLLY, C., MOODLEY, D., PADAYATCHI, N., RAMJEE, A., COOVADIA, H.M., and SULLIVAN, J.L. Vertical transmission of mycobacterium tuberculosis in KwaZulu Natal: Impact of HIV-1 co-infection. International Journal of Tuberculosis and Lung Disease 8(1): 59–69. Jan. 2004.
  172. PORCO, T.C., MARTIN, J.N., PAGE-SHAFER, K.A., CHENG, A., CHARLEBOIS, E., GRANT, R.M., and OSMOND, D.H. Decline in HIV infectivity following the introduction of highly active antiretroviral therapy. AIDS 18(1): 81–88. Jan. 2, 2004.
  173. POTTS, M. [Douching with lime juice] Personal communication, May 21, 2007.
  174. QUINN, T.C. and OVERBAUGH, J. HIV/AIDS in women: An expanding epidemic. Science 308(5728): 1582–1583. Jun. 10, 2005.
  175. QUINN, T.C., WAWER, M.J., SEWANKAMBO, N., SERWADDA, D., LI, C., WABWIRE-MANGEN, F., MEEHAN, M.O., LUTALO, T., and GRAY, R.H. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. New England Journal of Medicine 342(13): 921–929. Mar. 30, 2000.
  176. RABKIN, M., EL-SADR, W., and ABRAMS, E. Clinical care of adults. In: The Columbia Clinical Manual: Care and Treatment of HIV/AIDS in Resource-Limited Settings. International Center for AIDS Care and Treatment Programs, Columbia University Mailman School of Public Health, p. 88–157.
  177. RAO, S., YAJNIK, C.S., KANADE, A., FALL, C.H., MARGETTS, B.M., JACKSON, A.A., SHIER, R., JOSHI, S., REGE, S., LUBREE, H., and DESAI, B. Intake of micronutrient–rich foods in rural Indian mothers is associated with the size of their babies at birth: Pune Maternal Nutrition Study. Journal of Nutrition 131(4): 1217–1224. Apr. 2001.
  178. REYNOLDS, H.W. [Contraception’s proven potential to fight HIV] Personal communication, Mar. 23, 2007. (Updated from the original letter (2005) in Sexually Transmitted Infections)
  179. REYNOLDS, H.W. and WILCHER, R. Best kept secret in PMTCT: Contraception to avert unintended pregnancies. Jun. 1, 2006. (AIDSLink: Issue 97) 3 p.
  180. RICHARDSON, B.A., MORRISON, C.S., SEKADDE–KIGONDU, C., SINEI, S.K., OVERBAUGH, J., PANTELEEFF, D.D., WEINER, D.H., and KREISS, J.K. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS 13(15): 2091–2097. Oct. 22, 1999.
  181. RICHARDSON, B.A., OTIENO, P.A., MBORI-NGACHA, D., OVERBAUGH, J., FARQUHAR, C., and JOHN-STEWART, G.C. Hormonal contraception and HIV-1 disease progression among postpartum Kenyan women. AIDS 21(6): 749–753. Mar. 30, 2007.
  182. RIGOPOULOS, D., GREGORIOU, S., PAPARIZOS, V., and KATSAMBAS, A. AIDS in pregnancy, part I: Epidemiology, testing, effect on disease progression, opportunistic infections, and risk of vertical transmission. Skinmed 6(1): 18–23. Jan./Feb. 2007.
  183. ROCHAT, T.J., RICHTER, L.M., DOLL, H.A., BUTHELEZI, N.P., TOMKINS, A., and STEIN, A. Depression among pregnant rural South African women undergoing HIV testing. Journal of the American Medical Association 295(12): 1376–1378. Mar. 22, 2006.
  184. ROLLINS, N.C., COOVADIA, H.M., BLAND, R.M., COUTSOUDIS, A., BENNISH, M.L., PATEL, D., and NEWELL, M.L. Pregnancy outcomes in HIV-infected and uninfected women in rural and urban South Africa. Journal of Acquired Immune Deficiency Syndromes 44(3): 321–328. Mar. 1, 2007.
  185. ROSS, A., MORGAN, D., LUBEGA, R., CARPENTER, L.M., MAYANJA, B., and WHITWORTH, J.A. Reduced fertility associated with HIV: The contribution of pre-existing subfertility. AIDS 13(15): 2133–2141. Oct. 22, 1999.
  186. ROSS, A., VAN DER PAAL, L., LUBEGA, R., MAYANJA, B.N., SHAFER, L.A., and WHITWORTH, J. HIV-1 disease progression and fertility: The incidence of recognized pregnancy and pregnancy outcome in Uganda. AIDS 18(5): 799–804. Mar. 26, 2004.
  187. RWANDA MINISTRY OF HEALTH. Evaluation of access to and utilization of prevention of mother-to-child transmission (PMTCT) services of HIV in Rwanda. Kigali, TRAC, ICAP, EGPAF, Jan. 2007.
  188. RYDER, R.W., KAMENGA, C., JINGU, M., MBUYI, N., MBU, L., and BEHETS, F. Pregnancy and HIV-1 incidence in 178 married couples with discordant HIV-1 serostatus: Additional experience at an HIV-1 counselling centre in the Democratic Republic of the Congo. Tropical Medicine and International Health 5(7): 482–487. Jul. 2000.
  189. SAADA, M., LE CHENADEC, J., BERREBI, A., BONGAIN, A., DELFRAISSY, J.F., MAYAUX, M.J., and MEYER, L. Pregnancy and progression to AIDS: Results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS 14(15): 2355–2360. Oct. 20, 2000.
  190. SARNA, A., LUCHTERS, S., MUNYAO, P., OKAL, J., SHIKELY, K., MANDALIYA, K., and RUTENBERG, N. Fertility preferences and family planning experiences among ART clients in Mombasa, Kenya. Proceedings of the International Conference on Actions to Strengthen Linkages between Sexual and Reproductive Health and HIV/AIDS, Mumbai, Feb. 4–7, 2007.
  191. SAVASI, V., FERRAZZI, E., LANZANI, C., ONETA, M., PARRILLA, B., and PERSICO, T. Safety of sperm washing and ART outcome in 741 HIV-1-serodiscordant couples. Human Reproduction 22(3): 772–777. Mar. 2007.
  192. SEDGH, G., LARSEN, U., SPIEGELMAN, D., MSAMANGA, G., and FAWZI, W.W. HIV-1 disease progression and fertility in Dar es Salaam, Tanzania. Journal of Acquired Immune Deficiency Syndromes 39(4): 439–445. Aug. 1, 2005.
  193. SEMBA, R.D., MIOTTI, P.G., CHIPHANGWI, J.D., SAAH, A.J., CANNER, J.K., DALLABETTA, G.A., and HOOVER, D.R. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343(8913): 1593–1597. Jun. 25, 1994.
  194. SEMPRINI, A.E., VUCETICH, A., and HOLLANDER, L. Sperm washing, use of HAART and role of elective caesarean section. Current Opinion in Obstetrics and Gynecology 16(6): 465–470. Dec. 2004.
  195. SHELTON, J. Contraception for women on first-line antiretrovirals (ARVs). INFO Project at the Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs, Nov. 11, 2004. (Global Health Technical Briefs) 2 p.
  196. SHELTON, J.D. and PETERSON, E.A. The imperative for family planning in ART therapy in Africa. Lancet 364(9449): 1916–1918. Nov. 27-Dec. 3, 2004.
  197. SINEI, S.K., FORTNEY, J.A., KIGONDU, C.S., FELDBLUM, P.J., KUYOH, M., ALLEN, M.Y., and GLOVER, L.H. Contraceptive use and HIV infection in Kenyan family planning clinic attenders. International Journal of STD & AIDS 7(1): 65–70. Jan.–Feb. 1996.
  198. SINEI, S.K., MORRISON, C.S., SEKADDE-KIGONDU, C., ALLEN, M., and KOKONYA, D. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 351(9111): 1238–1241. Apr. 25, 1998.
  199. SINGH, R. Fertility and desire for children among HIV infected persons with special reference to Mumbai. Annual Meeting of the Population Association of America, Los Angeles, Mar. 30–Apr. 1, 2006. 17 p.
  200. SMART, T. PEPFAR: Unexpected and unwanted pregnancies in women on ART highlights family planning gap. Jul. 13, 2006. (AIDSmap)
  201. SMITH, D.K., GROHSKOPF, L.A., BLACK, R.J., AUERBACH, J.D., VERONESE, F., STRUBLE, K.A., CHEEVER, L., JOHNSON, M., PAXTON, L.A., ONORATO, I.M., and GREENBERG, A.E. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: Recommendations from the U.S. Department of Health and Human Services. Mortality and Morbidity Weekly Report Recommendations and Reports 54(RR-2): 1–20. Jan. 21, 2005.
  202. SMITH, D.M., RICHMAN, D.D., and LITTLE, S.J. HIV superinfection. Journal of Infectious Diseases 192(3): 438–444. Aug. 1, 2005.
  203. SPIERS, A., THOW, C., and WINTER, A. Case study—Sending sensitive results to patients secure online text messaging. Glasgow, National Health Service, Oct. 2005. 4 p.
  204. STANTON, C.K. and HOLTZ, S.A. Levels and trends in cesarean birth in the developing world. Studies in Family Planning 37(1): 41–48. Mar. 2006.
  205. STANWOOD, N.L., COHN, S.E., HEISER, J.R., and PUGLIESE, M. Contraception and fertility plans in a cohort of HIV-positive women in care. Contraception 75(4): 294–298. Apr. 2007.
  206. STOVER, J. Adding family planning to PMTCT sites increases the benefits of PMTCT. U.S. Agency for International Development Bureau for Global Health, Oct. 2003. (Issue Brief HIV/AIDS)
  207. STRACHAN, M., KWATENG-ADDO, A., HARDEE, K., SUMRAMANIAM, S., JUDICE, N., and AGARWAL, K. An anlysis of family planning content in HIV/AIDS, VCT, and PMTCT policies in 16 countries. POLICY, Jan. 2004. (POLICY Working Paper Series No 9) 38 p.
  208. STRINGER, E. [Lukasa randomized trial analysis] Personal communication, Jun. 4, 2007.
  209. STRINGER, E.M., KASEBA, C., LEVY, J., SINKALA, M., GOLDENBERG, R., CHI, B.H., MATONGO, I., VERMUND, S.H., MWANAHAMUNTU, M., and STRINGER, J.S. A randomized trial of the intrauterine contraceptive device (IUD) versus hormonal contraception in HIV-infected women. American Journal of Obstetrics and Gynecology. 2007. (In press)
  210. STUKIN, S. Baby love. POZ wire service Dec. 2002.
  211. SWEAT, M.D., O'REILLY, K.R., SCHMID, G.P., DENISON, J., and DE ZOYSA, I. Cost-effectiveness of nevirapine to prevent mother-to-child HIV transmission in eight African countries. AIDS 18(12): 1661–1671. Aug. 20, 2004.
  212. TAHA, T.E., HOOVER, D.R., DALLABETTA, G.A., KUMWENDA, N.I., MTIMAVALYE, L.A., YANG, L.P., LIOMBA, G.N., BROADHEAD, R.L., CHIPHANGWI, J.D., and MIOTTI, P.G. Bacterial vaginosis and disturbances of vaginal flora: Association with increased acquisition of HIV. AIDS 12(13): 1699–1706. Sep. 10, 1998.
  213. TANEEPANICHSKUL, S., INTARAPRASERT, S., PHUAPRADIT, W., and CHATURACHINDA, K. Use of Norplant implants in asymptomatic HIV-1 infected women. Contraception 55(4): 205–207. Apr. 1997.
  214. TANEEPANICHSKUL, S. and TANPRASERTKUL, C. Use of Norplant implants in the immediate postpartum period among asymptomatic HIV-1-positive mothers. Contraception 64(1): 39–41. Jul. 2001.
  215. TANG, A.M. and SMIT, E. Selected vitamins in HIV infection: A review. AIDS Patient Care and STDS 12(4): 263–273. Apr. 1998.
  216. TERRIS-PRESTHOLT, F., WATSON-JONES, D., MUGEYE, K., KUMARANAYAKE, L., NDEKI, L., WEISS, H., CHANGALUCHA, J., TODD, J., LISEKIE, F., GUMODOKA, B., MABEY, D., and HAYES, R. Is antenatal syphilis screening still cost effective in sub-Saharan Africa Sexually Transmitted Infections 79: 375–381. 2003.
  217. THACKWAY, S.V., FURNER, V., MIJCH, A., COOPER, D.A., HOLLAND, D., MARTINEZ, P., SHAW, D., VAN BEEK, I., WRIGHT, E., CLEZY, K., and KALDOR, J.M. Fertility and reproductive choice in women with HIV-1 infection. AIDS 11(5): 663–667. Apr. 1997.
  218. THORNE, C. and NEWELL, M.L. Safety of agents used to prevent mother-to-child transmission of HIV: Is there any cause for concern? Drug Safety 30(3): 203–213. 2007.
  219. TRUSSELL, J. Contraceptive efficacy. In: Contraceptive Technology. 18th ed. New York, Ardent Media, 2004. p. 773–845.
  220. TRUSSELL, J. Contraceptive efficacy. Hatcher, R.A., Trussell, J., Nelson, A.L., Cates, W., Stewart, F.H., and Kowal, D. In: Contraceptive Technology. 19th rev. ed. New York, Ardent Media, 2007. (In press)
  221. U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC). HIV/AIDS Surveillance Report, 2005. Atlanta, CDC, 2006. 46 p.
  222. UGANDA BUREAU OF STATISTICS. Uganda Demographic and Health Survey preliminary report. Kampala, Uganda and Calverton, Maryland, Uganda Bureau of Statistics and ORC Macro, Nov. 2006.
  223. UNITED NATIONS (UN). The Glion Call to Action on family planning and HIV/AIDS in women and children. UN, May 2004.
  224. VAN BEELEN, N. and BELL, E. Women living with HIV. Amsterdam, Royal Tropical Institute, 2006. (Exchange on HIV/AIDS, Sexuality and Gender
     No. 3) 20 p.
  225. VAN BENTHEM, B.H., VERNAZZA, P., COUTINHO, R.A., and PRINS, M. The impact of pregnancy and menopause on CD4 lymphocyte counts in HIV-infected women. AIDS 16(6): 919–924. Apr. 12, 2002.
  226. VAN DAMME, L., RAMJEE, G., ALARY, M., VUYLSTEKE, B., CHANDEYING, V., REES, H., SIRIVONGRANGSON, P., MUKENGE-TSHIBAKA, L., ETTIEGNE-TRAORE, V., UAHEOWITCHAI, C., KARIM, S.S., MASSE, B., PERRIENS, J., and LAGA, M. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 360(9338): 971–977. Sep. 28, 2002.
  227. VERNAZZA, P.L., TROIANI, L., FLEPP, M.J., CONE, R.W., SCHOCK, J., ROTH, F., BOGGIAN, K., COHEN, M.S., FISCUS, S.A., and ERON, J.J. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 14(2): 117–121. Jan. 28, 2000.
  228. VIJAYAKUMAR, G., MABUDE, Z., SMIT, J., BEKSINSKA, M., and LURIE, M. A review of female-condom effectiveness: Patterns of use and impact on protected sex acts and STI incidence. International Journal of STD and AIDS 17(10): 652–659. Oct. 2006.
  229. VILLAMOR, E., MSAMANGA, G., ABOUD, S., URASSA, W., HUNTER, D.J., and FAWZI, W.W. Adverse perinatal outcomes of HIV-1-infected women in relation to malaria parasitemia in maternal and umbilical cord blood. American Journal of Tropical Medicine and Hygiene 73(4): 694–697. Oct. 2005.
  230. VOLMINK, J., SIEGFRIED, N.L., VAN DER MERWE, L., and BROCKLEHURST, P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database of Systematic Reviews (2): 1–70. Wiley. 2007.
  231. WANG, C.C., MCCLELLAND, R.S., OVERBAUGH, J., REILLY, M., PANTELEEFF, D.D., MANDALIYA, K., CHOHAN, B., LAVREYS, L., NDINYA-ACHOLA, J., and KREISS, J.K. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 18(2): 205–209. Jan. 23, 2004
  232. WATTS, D.H., SPRINGER, G., MINKOFF, H., HILLIER, S.L., JACOBSON, L., MOXLEY, M., JUSTMAN, J., CEJTIN, H., O'CONNELL, C., and GREENBLATT, R.M. The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: Longitudinal findings of the women's interagency HIV study. Journal of Acquired Immune Deficiency Syndromes 43(2): 161–168. Oct. 1, 2006.
  233. WAWER, M.J., GRAY, R.H., SEWANKAMBO, N.K., SERWADDA, D., LI, X., LAEYENDECKER, O., KIWANUKA, N., KIGOZI, G., KIDDUGAVU, M., LUTALO, T., NALUGODA, F., WABWIRE-MANGEN, F., MEEHAN, M.P., and QUINN, T.C. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. Journal of Infectious Diseases 191(9): 1403–1409. May 1, 2005.
  234. WEISS, H.A., QUIGLEY, M.A., and HAYES, R.J. Male circumcision and risk of HIV infection in sub-Saharan Africa: A systematic review and meta-analysis. AIDS 14(15): 2361–2370. Oct 20.
  235. WELLER, S. and DAVIS, K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database of Systematic Reviews (1): 1–24. Wiley. Jan. 2002.
  236. WESTOFF, C.R. New estimates of unmet need and the demand for family planning. Calverton, Maryland, Macro International Inc., Dec. 2006. (DHS Comparative Reports No 14) 83 p.
  237. WHEELER, D.A. Weight loss and disease progression in HIV infection. AIDS Reader 9(5): 347–353. Aug. 1999.
  238. WILCOX, A.J., DUNSON, D.B., WEINBERG, C.R., TRUSSELL, J., and BAIRD, D.D. Likelihood of conception with a single act of intercourse: Providing benchmark rates for assessment of post-coital contraceptives. Contraception 63(4): 211–215. Apr. 2001.
  239. WILFERT, C.M. The joys--and the responsibilities of having children. The Body: The Complete HIV/AIDS Resource Oct. 1998.
  240. WILSON, T.E., GORE, M.E., GREENBLATT, R., COHEN, M., MINKOFF, H., SILVER, S., ROBISON, E., LEVINE, A., and GANGE, S.J. Changes in sexual behavior among HIV-infected women after initiation of HAART. American Journal of Public Health 94(7): 1141–1146. Jul. 2004.
  241. WILSON, T.E., MASSAD, L.S., RIESTER, K.A., BARKAN, S., RICHARDSON, J., YOUNG, M., GURTMAN, A., and GREENBLATT, R. Sexual, contraceptive, and drug use behaviors of women with HIV and those at high risk for infection: Results from the Women's Interagency HIV Study. AIDS 13(5): 591–598. Apr. 1, 1999.
  242. WOMEN'S GLOBAL HEALTH IMPERATIVE. Methods for improving reproductive health in Africa: Effectiveness of the diaphragm for HIV prevention. 2007.
  243. WORLD BANK. Information and communications for development: Global trends and policies. Washington DC, The World Bank, 2006. 332 p.
  244. WORLD BANK GROUP. Health, nutrition, and population statistics: 2005 Demographic projections
     <http://devdata.worldbank.org/hnpstats/dp1.asp> World Bank Group, 2005
  245. WORLD HEALTH ORGANIZATION (WHO). Prevention of HIV in infants and young children: Review of evidence and WHO's activities. Geneva, WHO, 2002. 6 p.
  246. WORLD HEALTH ORGANIZATION (WHO). Strategic approaches to the prevention of HIV infection in infants. Geneva, WHO, 2003.
  247. WORLD HEALTH ORGANIZATION (WHO). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings. Geneva, WHO, 2004. 50 p.
  248. WORLD HEALTH ORGANIZATION (WHO). Medical eligibility criteria for contraceptive use. 3rd ed. Geneva, WHO, 2004. 168 p.
  249. WORLD HEALTH ORGANIZATION (WHO). Selected practice recommendations for contraceptive use. 2nd ed. Geneva, WHO, 2005. 170 p.
  250. WORLD HEALTH ORGANIZATION (WHO). Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Towards universal access. Recommendations for a public health approach. 2006 version. Geneva, WHO, 2006. 88 p.
  251. WORLD HEALTH ORGANIZATION (WHO). Reproductive choices and family planning for people living with HIV: Counselling tool. Geneva, WHO, 2006.
  252. WORLD HEALTH ORGANIZATION (WHO). WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. Geneva, WHO, 2006. 48 p.
  253. WORLD HEALTH ORGANIZATION (WHO). WHO HIV and infant feeding technical consultation held on behalf of the Inter-Agency Task Team (IATT) on prevention of HIV infections in pregnant women, mothers and their infants in Geneva, October 25–27, 2006. Consensus statement. Geneva, WHO, 2006. 5 p.
  254. WORLD HEALTH ORGANIZATION (WHO). Review of priorities in research on hormonal contraception and IUDs in HIV infection: Report of a technical consultation
    Geneva, WHO, 2007. (In press)
  255. WORLD HEALTH ORGANIZATION (WHO) and CONTRACEPTIVE RESEARCH AND DEVELOPMENT PROJECT (CONRAD). Safety of nonoxynol-9 when used for contraception: Report from WHO/CONRAD technical consultation. Geneva, Oct. 2001. 23 p.
  256. WORLD HEALTH ORGANIZATION (WHO) and JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH/CENTER FOR COMMUNICATION PROGRAMS (CCP) INFO PROJECT. Family planning: A global handbook for providers. Baltimore and Geneva, CCP and WHO, 2007.
  257. WORLD HEALTH ORGANIZATION (WHO) AND JOINT UN PROGRAMME ON HIV/AIDS (UNAIDS). Progress on global access to HIV antiretroviral therapy: A report on 3 by 5 and beyond. Geneva, WHO, 2006. 84 p.
  258. WORLD HEALTH ORGANIZATION (WHO). Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2006 revision. Genevea, WHO, 2006. 128 p.
  259. ZABA, B., TERCEIRA, N., MASON, P., and GREGSON, S. The contribution of HIV to fertility decline in rural Zimbabwe, 1985–2000. Population Studies 57(2): 149–164. 2003.
  260. ZHENG, J. Data from the United States Food and Drug Administration. Journal of Acquired Immune Deficiency Syndromes 38(Suppl. 1): S24–S26. Mar. 2005.


Back to top

Disclaimer: The information provided on this web site is not official U.S. Government information and does not represent the views or positions of the U.S. Agency for International Development, the U.S. Government or The Johns Hopkins University.